# Verve Therapeutics, Inc. — Form D

Verve Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-22. The offering totals $94.0M, of which $94.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-01-22
- Form: D
- Accession: 0001840574-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $94.0M
- Amount sold: $94.0M
- Investors: 22
- Date of first sale: 2021-01-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-387112

## Issuer

- Name: Verve Therapeutics, Inc.
- CIK: 0001840574
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 500 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 02139
- Phone: (978) 501-3026

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Burt Adelman | Director | Cambridge, MA |
| John Evans | Director | West Haven, CT |
| Sekar Kathiresan | Director | Cambridge, MA |
| Anthony Philippakis | Director | Cambridge, MA |
| Krishna Yeshwant | Director | New York, NY |
| Andrew Ashe | Executive Officer | Cambridge, MA |
| Andrew Bellinger | Executive Officer | WATERTOWN, MA |
| Sekar Kathiresan | Executive Officer | Cambridge, MA |

## More

- [CIK 1840574 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1840574&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001840574-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.